- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
Authors
Keywords
-
Journal
ADVANCES IN THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-02
DOI
10.1007/s12325-021-01761-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
- (2021) Jing-Hui Tian et al. Nature Communications
- T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression
- (2021) Francisco Javier Gil-Etayo et al. Frontiers in Cellular and Infection Microbiology
- Incidence and Impact of COVID-19 in MS
- (2021) Maria Sepúlveda et al. Neurology-Neuroimmunology & Neuroinflammation
- COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
- (2021) Anthony T. Reder et al. CNS DRUGS
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
- (2021) Amber Salter et al. JAMA Neurology
- Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States
- (2021) Dawn M. Ehde et al. Multiple Sclerosis and Related Disorders
- Tick-borne encephalitis vaccination in multiple sclerosis
- (2020) Alexander Winkelmann et al. Neurology-Neuroimmunology & Neuroinflammation
- Contrasting effects of B cell depletion on CD4 + and CD8 + memory T cell responses generated after transplantation
- (2020) Jose Marino et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Revisiting the role of CD4+ T cells in cancer immunotherapy—new insights into old paradigms
- (2020) Rong En Tay et al. CANCER GENE THERAPY
- Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
- (2020) Alba Grifoni et al. CELL
- A Dynamic Immune Response Shapes COVID-19 Progression
- (2020) Eugenia Ziying Ong et al. Cell Host & Microbe
- Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
- (2020) Ling Ni et al. IMMUNITY
- Site-specific glycan analysis of the SARS-CoV-2 spike
- (2020) Yasunori Watanabe et al. SCIENCE
- Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series
- (2020) E. Signoriello et al. Multiple Sclerosis and Related Disorders
- Varicella Zoster immunity loss in multiple sclerosis patient treated with ocrelizumab
- (2020) L. Rapisarda et al. CLINICAL IMMUNOLOGY
- Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices
- (2020) Farrah J. Mateen et al. JOURNAL OF NEUROLOGY
- Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity
- (2020) Erin E Longbrake et al. Multiple Sclerosis Journal
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
- (2020) Kizzmekia S. Corbett et al. NATURE
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
- (2020) Jose Mateus et al. SCIENCE
- A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
- (2020) Colin D. Funk et al. Frontiers in Pharmacology
- Infections in patients diagnosed with multiple sclerosis: A multi-database study
- (2020) R. Persson et al. Multiple Sclerosis and Related Disorders
- Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
- (2020) Martina Severa et al. Frontiers in Immunology
- Technological Approaches for Improving Vaccination Compliance and Coverage
- (2020) Céline Lemoine et al. Vaccines
- Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register
- (2020) Nikos Evangelou et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Vaccinations in patients with multiple sclerosis: A Delphi consensus statement
- (2020) Agostino Riva et al. Multiple Sclerosis Journal
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infections in patients with multiple sclerosis: A national cohort study in Sweden
- (2020) Anna Castelo-Branco et al. Multiple Sclerosis and Related Disorders
- Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly
- (2020) Branca Pereira et al. Frontiers in Immunology
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
- (2020) Ana Zabalza et al. EUROPEAN JOURNAL OF NEUROLOGY
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases
- (2020) Nora Möhn et al. Journal of Clinical Medicine
- Immunogenicity of The Influenza Vaccine in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
- (2020) Jackie Nguyen et al. Multiple Sclerosis and Related Disorders
- Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA–triggered innate immune responses
- (2019) Charles E. Samuel JOURNAL OF BIOLOGICAL CHEMISTRY
- Factors That Influence the Immune Response to Vaccination
- (2019) Petra Zimmermann et al. CLINICAL MICROBIOLOGY REVIEWS
- Immunization and multiple sclerosis: Recommendations from the French multiple sclerosis society
- (2019) Christine Lebrun et al. Multiple Sclerosis and Related Disorders
- Rituximab treatment for multiple sclerosis
- (2019) Benjamin V Ineichen et al. Multiple Sclerosis Journal
- Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosis
- (2019) Mauricio F. Farez et al. NEUROLOGY
- Nasal route for vaccine and drug delivery: Features and current opportunities
- (2019) Yadira Lobaina Mato INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
- (2018) S. G. Berntsson et al. ACTA NEUROLOGICA SCANDINAVICA
- Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy
- (2018) H. K. Olberg et al. EUROPEAN JOURNAL OF NEUROLOGY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- The Evolving Mechanisms of Action of Glatiramer Acetate
- (2018) Thomas Prod'homme et al. Cold Spring Harbor Perspectives in Medicine
- Infectious Complications of Multiple Sclerosis Therapies: Implications for Screening, Prophylaxis, and Management
- (2018) David J Epstein et al. Open Forum Infectious Diseases
- Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies
- (2018) Christoph Metze et al. CNS Neuroscience & Therapeutics
- Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis
- (2018) Manuela Flórido et al. Mucosal Immunology
- The effect of immunosuppressive agents on immunogenicity of pneumococcal vaccination: A systematic review and meta-analysis
- (2018) Mariëlle van Aalst et al. VACCINE
- T Cell/B Cell Collaboration and Autoimmunity: An Intimate Relationship
- (2018) Lina Petersone et al. Frontiers in Immunology
- Standardization of Hemagglutination Inhibition Assay for Influenza Serology Allows for High Reproducibility between Laboratories
- (2016) Mary Zacour et al. Clinical and Vaccine Immunology
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Race-related differences in antibody responses to the inactivated influenza vaccine are linked to distinct pre-vaccination gene expression profiles in blood
- (2016) Raj Kurupati et al. Oncotarget
- Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity
- (2016) Erin E. Longbrake et al. JAMA Neurology
- Structure, Function, and Evolution of Coronavirus Spike Proteins
- (2016) Fang Li Annual Review of Virology
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis
- (2015) L. Kappos et al. NEUROLOGY
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation
- (2015) Andrew J. Steelman Frontiers in Immunology
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Differential Effects of the Type I Interferons 4, , and on Antiviral Activity and Vaccine Efficacy
- (2014) S. L. Day et al. JOURNAL OF IMMUNOLOGY
- Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis
- (2014) Michael Kaufman et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
- (2014) R. Channappanavar et al. JOURNAL OF VIROLOGY
- Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study
- (2014) Henning K Olberg et al. Multiple Sclerosis Journal
- VZV encephalitis that developed in an immunized patient during fingolimod therapy
- (2014) N. P. Issa et al. NEUROLOGY
- Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
- (2014) Nathalie Muls et al. PLoS One
- BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety
- (2013) Robert J. Fox et al. CURRENT MEDICAL RESEARCH AND OPINION
- Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
- (2013) A. Bar-Or et al. NEUROLOGY
- Immune competence after alemtuzumab treatment of multiple sclerosis
- (2013) C. L. McCarthy et al. NEUROLOGY
- Preserved Antigen-Specific Immune Response in Patients with Multiple Sclerosis Responding to IFNβ-Therapy
- (2013) Matthias Mehling et al. PLoS One
- Generation of Effector Memory T Cell-Based Mucosal and Systemic Immunity with Pulmonary Nanoparticle Vaccination
- (2013) A. V. Li et al. Science Translational Medicine
- RNA: The new revolution in nucleic acid vaccines
- (2013) Andrew J. Geall et al. SEMINARS IN IMMUNOLOGY
- Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: An observer-blind, randomized trial
- (2013) William H. Yang et al. VACCINE
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
- Varicella vaccination after fingolimod: A case report
- (2013) Joseph R. Berger Multiple Sclerosis and Related Disorders
- CD4+T Cells: Differentiation and Functions
- (2012) Rishi Vishal Luckheeram et al. Clinical & Developmental Immunology
- Humoral immune response to influenza vaccine in natalizumab-treated MS patients
- (2012) Mattias Vågberg et al. NEUROLOGICAL RESEARCH
- Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study
- (2011) Cem Gabay et al. ARTHRITIS AND RHEUMATISM
- Immunization in the adult immunocompromised host
- (2011) Micha Löbermann et al. AUTOIMMUNITY REVIEWS
- T-cell-inducing vaccines - what’s the future
- (2011) Sarah C. Gilbert IMMUNOLOGY
- Pharmacodynamic Effects of Steady-State Fingolimod on Antibody Response in Healthy Volunteers: A 4-Week, Randomized, Placebo-Controlled, Parallel-Group, Multiple-Dose Study
- (2011) Craig Boulton et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Temporal relationship between environmental influenza A and Epstein–Barr viral infections and high multiple sclerosis relapse occurrence
- (2011) Mervi Oikonen et al. Multiple Sclerosis Journal
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Distribution of Primed T Cells and Antigen-Loaded Antigen Presenting Cells Following Intranasal Immunization in Mice
- (2011) Annalisa Ciabattini et al. PLoS One
- Antigen-specific adaptive immune responses in fingolimod-treated multiple sclerosis patients
- (2010) Matthias Mehling et al. ANNALS OF NEUROLOGY
- Overlapping and distinct mechanisms of action of multiple sclerosis therapies
- (2010) J.J. Graber et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- A key role for lung-resident memory lymphocytes in protective immune responses after BCG vaccination
- (2010) Lisa M. Connor et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Systems Vaccinology
- (2010) Bali Pulendran et al. IMMUNITY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Adaptive immunity
- (2010) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Innate immunity
- (2009) Stuart E. Turvey et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Requirement of B Cells for Generating CD4+ T Cell Memory
- (2009) J. K. Whitmire et al. JOURNAL OF IMMUNOLOGY
- Interferon Beta–Induced Restoration of Regulatory T-Cell Function in Multiple Sclerosis Is Prompted by an Increase in Newly Generated Naive Regulatory T Cells
- (2008) Mirjam Korporal et al. ARCHIVES OF NEUROLOGY
- The effect of β-interferon therapy on myelin basic protein-elicited CD4+ T cell proliferation and cytokine production in multiple sclerosis
- (2008) Chris J. Hedegaard et al. CLINICAL IMMUNOLOGY
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started